Neurogene Inc.
Neurogene Inc. (NGNE) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
ngne · stock forecast · 6 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 6 Wall Street analysts in the past 3 months
Buy
6 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$70.00
Consensus
$69.50
+143.0% upside
Low
$69.00
Median: $69.5 · Last Close: $28.60
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$69.50
143.0% upside
High Target
$70
144.8%
Low Target
$69
141.3%
Current Price
$28.60
as of today
Based on analyst price targets, the NGNE stock price prediction for the next 12 months ranges from $69 to $70. The consensus NGNE price forecast of $69.50 implies 143.0% upside from the current price of $28.60.
Short-Term Price Prediction
BullAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $27.39 | ↓ 4.23% |
1-day model range: $27.19–$27.59. Peak: $27.59 (-4.23%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $16 | -45.5% |
| 2028 | $12 | -59.2% |
| 2029 | $10 | -64.8% |
| 2030 | $9 | -67.4% |
| 2031 | — | -68.8% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · NGNE · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-04-06 | Canaccord Genuity | Maintains | Buy→Buy |
| 2026-01-13 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-11-13 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-10-31 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-10-09 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-06-12 | BMO Capital | Maintains | Outperform→Outperform |
| 2025-05-20 | BMO Capital | Maintains | Outperform→Outperform |
| 2025-05-16 | Baird | Downgrade ↓ | Outperform→Neutral |
| 2025-05-13 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-04-14 | BMO Capital | Maintains | Outperform→Outperform |
Wall Street analysts have recently issued updated ratings on Neurogene Inc. (NGNE) stock. Of the recent 29 rating actions, 0 were upgrades and 1 were downgrades. 6 analysts currently cover NGNE.
Analyst Recommendation Trends
NGNE analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$0M
↓ 99.3% YoY
Revenue Next Year
$0M
↓ 100.0% YoY
EPS This Year
$-5.57
EPS Next Year
$-5.53
↓ 0.9% YoY
EPS ForecastReported vs Estimated
Analysts forecast NGNE EPS of $-5.57 for the current fiscal year, based on estimates from 7 analysts. The NGNE revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The NGNE stock forecast is supported by two independent data sources: analyst consensus ratings from 6 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus NGNE price target is $69.50 (+143.0% upside), with an analyst consensus of Buy.
The NGNE short-term stock prediction for tomorrow is $27.39 (-4.23%). The NGNE stock price prediction for 2027 estimates an average of $16. The NGNE stock prediction for 2030 projects a range of $9–$10.
Neurogene Inc. trades on NASDAQ under the ticker NGNE. The NGNE stock outlook for 2027 is broadly positive, supported by a Buy consensus among 83% of covering analysts.
Frequently asked questions
NGNE forecast · 8 questionsAccording to 6 Wall Street analysts, the average 12-month NGNE price target is $69.50, with a high forecast of $70.00 and a low of $69.00. The median price target is shown in the chart above when available. This implies +143.0% potential upside from the current price of $28.60.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.